• HOME
  • ABOUT
    • VISION SCIENCE RESEARCH
  • DRC
    • Department of Research Collaboration
  • DTC
    • Department of Technology Commercialization
  • RESEARCHERS
    • Our Co-Researchers
  • CONTACT
First slide
First slide
First slide
DTC / Technology Commercialization/Pharmacology

Contact us

Email*
First name*
Surname
Country*
I am representing*
Enquiry Subject*
0/100
Your enquiry*
0/1900
Technology Commercialization
Medicine Engineering Computer Science Material Agriculture Pharmacology Energy Geology Physics Chemistry Biology Food Science
Last update:22 Apr 2022

Studying Adsorption and Cellular Toxicity of Boron Nitride Nanostructure versus Melphalan Anti-ovarian Cancer Drug.

Inclusion of anticancer drugs into biocompatible nanoparticulate carriers decreases the general toxicity and improves the efficacy of clinical treatments due to the reduction of soluble circulating free drug.

The loading and release properties of exfoliated kaolinite/cellulose composite (EXK/CF) as a carrier for Oxaliplatin drug: cytotoxicity and release kinetics

Kaolinite layers were exfoliated as single sheets and admixed with cellulose fibers, forming an advanced exfoliated kaolinite/cellulose fiber (EXK/CF) composite, which was characterized as a promising carrier for the oxaliplatin (OL) drug to induce safety as well as the therapeutic effect.

Enhanced activity of vancomycin by encapsulation in hybrid magnetic nanoparticles conjugated to a cell-penetrating peptide

We describe a novel antibiotic delivery system based on magnetic nanoparticles (NPs) conjugated to a cell-penetrating peptide (CPP).
  • HOME|
  • ABOUT|
  • DRC |
  • DTC|
  • RESEARCHERS|
  • CONTACT
Vision Science Research © 2016 All Rights Reserved Terms of Use and Privacy Policy

VISION SCIENCE RESEARCH SDN BHD, which is short for VSR, is a mature international academic exchange platform jointly established by worldwide universities, research institutes and enterprises in Malaysia.